Sanofi Consumer Healthcare India (SANOFICONR) Fundamentals 2026 — P/E 41.2x, Revenue Analysis | SniperIQ
Sanofi Consumer Healthcare India (SANOFICONR) is a India-listed Healthcare company in Drug Manufacturers - General with a market capitalization of ₹10,630 Crore, trading at ₹4615.40 on the NSE. This SniperIQ fundamentals page covers Sanofi Consumer Healthcare India's valuation (P/E 41.2x, P/B 27.7x), profitability (net margin 27.6%), revenue (₹878 Crore in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Sanofi Consumer Healthcare India's market cap?
Sanofi Consumer Healthcare India (SANOFICONR) has a market capitalization of approximately ₹10,630 Crore, trading at ₹4615.40 on the NSE. Market cap moves with the live share price.
What is Sanofi Consumer Healthcare India's P/E ratio?
Sanofi Consumer Healthcare India's trailing twelve-month P/E ratio is 41.2x, with a price-to-book (P/B) of 27.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Sanofi Consumer Healthcare India?
Sanofi Consumer Healthcare India runs a net profit margin of 27.6%, a gross margin of 69.4%, and an operating margin of 34.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Sanofi Consumer Healthcare India generate?
Sanofi Consumer Healthcare India reported revenue of ₹878 Crore for fiscal year 2025, with net income of ₹240 Crore and earnings per share (EPS) of 104.27. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Sanofi Consumer Healthcare India pay a dividend?
Sanofi Consumer Healthcare India offers a trailing dividend yield of about 1.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Sanofi Consumer Healthcare India financially healthy?
Sanofi Consumer Healthcare India carries a debt-to-equity ratio of 0.06x and a current ratio of 3.85x, with a market beta of 0.75. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Sanofi Consumer Healthcare India a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Sanofi Consumer Healthcare India (SANOFICONR) the key facts are: market cap ₹10,630 Crore, P/E 41.2x, revenue ₹878 Crore, 52-week range 3975-5512. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Sanofi Consumer Healthcare India's full fundamentals live
Get Sanofi Consumer Healthcare India's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.